Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia (Q84358949)
Jump to navigation
Jump to search
scientific article published on 05 June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia |
scientific article published on 05 June 2010 |
Statements
Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia (English)
Francisco Javier Peñalver
Alberto Alvarez-Larrán
Laura Gallur
Isidro Jarque
Dolores Caballero
Joaquín Díaz-Mediavilla
Rosalía Bustelos
José Rafael Cabrera
Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA